Introduction of Lagicad 5000 IU Injection

• ​Lagicad 5000 IU Injection is a chemotherapy drug (also known as an antineoplastic or cytotoxic drug). Lagicad 5000 IU Injection is used in combination with other cancer drugs for the treatment of Acute Lymphoblastic Leukemia (ALL), a cancer that affects the blood and bone marrow. Lagicad 5000 IU Injection is also effective in treating various other blood disorders. Lagicad 5000IU works by breaking down a chemical present in cancer cells, which prevents the cancer cells from dividing and growing. The Lagicad 5000 IU Injection is administered through injection, either into a vein or under the skin.
  
  ​Lagicad 5000 IU Injection may cause some common adverse effects including weakness, loss of appetite, diarrhoea, epigastric pain, swelling over hands/ feet and ankles, injection site reaction (like pain, redness, and swelling), irritability, ​headache, tiredness, irritability, stomach cramps, weight loss. If you experience any side effects while using Lagicad 5000 IU Injection, it is important to inform your doctor. Additionally, Lagicad 5000IU and its components should be avoided if you have a known allergy to them.
  
  ​Before taking this Lagicad 5000 IU Injection, you should inform your doctor about any medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and herbal remedies. It is also important to avoid taking aspirin or aspirin-containing products unless specifically approved by your doctor. Additionally, do not receive any vaccinations or immunizations without the approval of your doctor. If you are pregnant or may become pregnant, it is important to inform your doctor before starting treatment. Benefits of Lagicad 5000 IU Injection is classified as a Pregnancy Category C drug, meaning that it should only be used during pregnancy if the benefits to the mother outweigh the potential risks to the fetus. Both men and women should avoid conceiving a child while taking Lagicad 5000 IU Injection, and barrier methods of contraception, such as condoms, are recommended. It is important to discuss with your doctor when it is safe to become pregnant or conceive a child after completing Lagicad 5000IU therapy.​
  

Uses of Lagicad 5000 IU Injection

• Lagicad 5000 IU Injection is used in the treatment of Acute Lymphoblastic Leukemia (ALL), which is a type of cancer that affects the blood and bone marrow. Acute Lymphoblastic Leukemia is characterized by the uncontrolled growth and division of immature lymphocytes, which are a type of white blood cell that helps fight infections in the body. This leads to the accumulation of cancerous cells in the bone marrow and blood, which can cause a variety of symptoms such as fatigue, weakness, fever, infections, bruising or bleeding easily, swollen lymph nodes, and bone pain. Lagicad 5000IU works by targeting the cancer cells and preventing them from dividing and growing, which helps to slow down or stop the progression of the disease.​
  

Benefits of Lagicad 5000 IU Injection

• ​Lagicad 5000 IU Injection which contains the active ingredient L-Asparaginase. Lagicad 5000 IU Injection is used to treat certain cancer types, including acute Lymphoblastic Leukemia (ALL). Lagicad 5000 IU Injection by killing or inhibiting the growth of cancer cells and impeding the multiplication of cancer cells. It is a potent and highly toxic medication, and you should discuss its potential risks and benefits with your doctor before undergoing treatment. During treatment with Lagicad 5000IU, it is recommended to avoid consuming alcohol and maintain proper hydration by drinking plenty of water.​
  

Side Effects of Lagicad 5000 IU Injection

• Like all medications, Lagicad 5000 IU Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.​
  

Most Common Side Effects of Lagicad 5000 IU Injection

• • Nausea
    
  • Vomiting
  • Weakness
  • Loss of appetite
  • Diarrhoea
  • Epigastric pain
  • Swelling over hands/ feet and ankles
  • Injection site reaction (like pain, redness, swelling)
  • Irritability

Common Side Effects of Lagicad 5000 IU Injection

• • Drowsiness
    
  • Acute Pancreatitis (Pain in abdomen, unable to eat, swollen and tender abdomen, Rapid pulse)
  • ​Headache
  • Tiredness
  • Irritability
  • Stomach cramps
  • Weight loss

How to Use Lagicad 5000 IU Injection?

• ​Lagicad 5000 IU Injection is typically administered either intravenously (into a vein) or intramuscularly (into a muscle). It is important to note that the medication should be administered by a healthcare professional or nurse in a hospital or clinic setting, as the specific dosing and administration of the medication will depend on the patient's clinical condition, age, medical history, type of cancer, and other factors. Benefits of Lagicad 5000 IU Injection is not recommended for patients to self-administer this medication, and it is important to follow the instructions of the healthcare professional administering Lagicad 5000 IU Injection to ensure the medication is safely and effectively administered.​
  

How Lagicad 5000 IU Injection Works?

• Lagicad 5000 IU Injection is a chemotherapy drug used to treat certain types of cancer, particularly acute lymphoblastic leukaemia (ALL). The active ingredient in the Lagicad 5000IU is L-asparaginase, an enzyme that works by breaking down asparagine, an amino acid that is important for the growth and survival of cancer cells. Since cancer cells cannot produce asparagine on their own, they rely on acquiring it from the bloodstream. Benefits of Lagicad 5000 IU Injection disrupts this process by breaking down asparagine into aspartic acid and ammonia, depriving cancer cells of this essential nutrient. Lagicad 5000IU can help slow down or even stop the growth of cancer cells.​

Safety Advices Lagicad 5000 IU Injection

Liver

Use with Caution

Lagicad 5000IU should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Benefits of Lagicad 5000 IU Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Lagicad 5000 IU Injection may need to be adjusted in patients with liver disease.

Breastfeeding

Unsafe

It is not recommended to breastfeed while taking Benefits of Lagicad 5000 IU Injection. Lagicad 5000IU may pass into breast milk and harm the infant. If you are breastfeeding and taking Lagicad 5000 IU Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.

Pregnancy

Unsafe

Use of Lagicad 5000 IU Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Lagicad 5000IU during pregnancy. Your doctor can help you make the best decision for you and your baby's health.

Driving

Safe

Lagicad 5000 IU Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Lagicad 5000IU such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.

Alcohol

Unsafe

It is generally not recommended to drink alcohol while taking Lagicad 5000 IU Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.

Kidney

Use with Caution

Lagicad 5000IU should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Benefits of Lagicad 5000 IU Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Benefits of Lagicad 5000 IU Injection may need to be adjusted in patients with kidney disease.